Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression (Q26785362)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26416466%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26416466%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26416466%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Vera Cappelletti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26416466%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Elda Tagliabue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26416466%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Maria Grazia Daidone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26416466%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Giuseppe Merlino

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26416466%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

language of work or name

English

0 references

publication date

28 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26416466%20AND%20SRC:MED&resulttype=core&format=json

Seminars in Cancer Biology

25 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26416466%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26416466%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

3-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26416466%20AND%20SRC:MED&resulttype=core&format=json

Multiwell stiffness assay for the study of cell responsiveness to cytotoxic drugs

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

New insights into the role of extracellular matrix during tumor onset and progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Differential gene expression profile in breast cancer-derived stromal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

SPARC: a matricellular regulator of tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Extracellular matrix components in breast cancer progression and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Molecular characterization of the tumor microenvironment in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Tensional homeostasis and the malignant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Regulation of in situ to invasive breast carcinoma transition

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Matrix crosslinking forces tumor progression by enhancing integrin signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Tumors as organs: complex tissues that interface with the entire organism

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

The tumor microenvironment is a dominant force in multidrug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Progression from ductal carcinoma in situ to invasive breast cancer: revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

The impact of tumor stroma on drug response in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Putting tumours in context

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Can shear-wave elastography predict response to neoadjuvant chemotherapy in women with invasive breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

The fibromatosis signature defines a robust stromal response in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Endogenous human microRNAs that suppress breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Pregnancy-associated breast cancer and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

A tense situation: forcing tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Clinical and epidemiological issues in mammographic density.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

The extracellular matrix: a dynamic niche in cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Elastic moduli of normal and pathological human breast tissues: an inversion-technique-based investigation of 169 samples.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Knockdown of osteopontin chemosensitizes MDA-MB-231 cells to cyclophosphamide by enhancing apoptosis through activating p38 MAPK pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Evidence for a crossover in breast cancer risk factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Microenvironment, tumor cell plasticity, and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Illustrating the interplay between the extracellular matrix and microRNAs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Breast cancer precursors revisited: molecular features and progression pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Normalization of the vasculature for treatment of cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

LOXL2-mediated matrix remodeling in metastasis and mammary gland involution

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Stromal responses among common carcinomas correlated with clinicopathologic features

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

miR-31 is a broad regulator of β1-integrin expression and function in cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Collagen density promotes mammary tumor initiation and progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Gene expression signatures of morphologically normal breast tissue identify basal-like tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Gene expression profiling of the tumor microenvironment during breast cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Gro

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Determination of stromal signatures in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Evidence that breast tissue stiffness is associated with risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

The extracellular matrix modulates the hallmarks of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

microRNA-mediated regulation of the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FJ.SEMCANCER.2015.09.012

7 January 2021

10.1016/J.SEMCANCER.2015.09.012

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

1533525

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26416466%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1533525

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

1533525

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26416466%20AND%20SRC:MED&resulttype=core&format=json